Kim Stobbelaar

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Respiratory Syncytial Virus

Respiratory Tract

Top Venues

Microbiology spectrum

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Kim Stobbelaar, Benedicte Y De Winter, Annemieke Smet, Stijn Verhulst, Peter Luc Delputte
Reply to Amarin et al., "Selection bias may compromise our understanding of the clinical significance of the co-detection of respiratory viruses". Microbiology spectrum (2024)
Sofie Schaerlaekens, Lotte Jacobs, Kim Stobbelaar, Paul Cos, Peter Luc Delputte
All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design? Vaccines 12 (1) (2024)
Sofie Schaerlaekens, Lotte Jacobs, Kim Stobbelaar, Paul Cos, Peter Luc Delputte
All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design? Vaccines 12 (1) (2024)
Sofie Schaerlaekens, Lotte Jacobs, Kim Stobbelaar, Paul Cos, Peter Luc Delputte
All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design? Vaccines 12 (1) (2024)
Kim Stobbelaar, Thomas C Mangodt, Winke Van der Gucht, Lise Delhaise, Jasmine Andries, Valérie Gille, Cyril Barbezange, Annemieke Smet, Benedicte Y De Winter, Jozef J De Dooy, Tom Schepens, Els L I M Duval, Paul Cos, Philippe G Jorens, Stijn Verhulst, Peter Luc Delputte
Risk Factors Associated with Severe RSV Infection in Infants: What Is the Role of Viral Co-Infections? Microbiology spectrum (2023)
Lionel Sacconnay, Jonathan De Smedt, Vera Rocha-Perugini, Edison Ong, Romuald Mascolo, Anne Atas, Carline Vanden Abeele, Magali de Heusch, Nathalie De Schrevel, Marie-Pierre David, Badiaa Bouzya, Kim Stobbelaar, Yannick Vanloubbeeck, Peter Luc Delputte, Corey P Mallett, Nancy Dezutter, Lucile Warter
The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains. Science translational medicine 15 (710) (2023)